Patent Assignment
Reel/Frame 059052/0271
Assignment of Assignor's Interest
Recorded: 2022-02-18
Pages: 3
Assignor
SPARCBIO LLC
Executed: 2021-10-26
Assignee
GIRAFPHARMA LLC
P.O. BOX 318009, SAN FRANCISCO, CALIFORNIA, 94131-9991
Covered Properties
(2)
1,8-Naphthyridinone Compounds and Uses Thereof
Patent:
11,254,670 →
Application:
16/746,769 →
Publication:
US 2020/0231589
PCT:
PCT/US2020/014208 ↗
1,8-Naphthyridinone Compounds and Uses Thereof
Application:
17/675,494 →
Publication:
US 2022/0169648
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2022
From: JADHAVAR, PRADEEP S.; MULIK, BABAN MOHAN; KHAN, FARHA; RAMACHANDRAN, SREEKANTH A.
To: INTEGRAL BIOSCIENCES PVT. LTD.
Reel/Frame 059719/0686 →
Assignment of Assignor's Interest
Feb 18, 2022
From: PHAM, SON MINH; KANKANALA, JAYAKANTH
To: SPARCBIO LLC
Reel/Frame 059052/0107 →
Assignment of Assignor's Interest
Feb 18, 2022
From: INTEGRAL BIOSCIENCES PVT. LTD.
To: SPARCBIO LLC
Reel/Frame 059052/0178 →
Assignment of Assignor's Interest
Feb 18, 2022
From: GIRAFPHARMA LLC
To: NUVATION BIO OPERATING COMPANY INC.(FORMALLY KNOWN AS NUVATION BIO INC.)
Reel/Frame 059052/0337 →
Assignment of Assignor's Interest
Feb 18, 2022
From: NUVATION BIO OPERATING COMPANY LLC (FORMALLY NUVATION BIO OPERATING COMPANY INC., WHICH WAS FORMALLY KNOWN AS NUVATION BIO INC.)
To: NUVATION BIO INC.
Reel/Frame 059052/0471 →
Change of Name
Feb 18, 2022
From: NUVATION BIO OPERATING COMPANY INC.
To: NUVATION BIO OPERATING COMPANY LLC
Reel/Frame 059202/0910 →
Security Interest
Mar 4, 2025
From: NUVATION BIO INC.
To: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
Reel/Frame 070400/0200 →
Release of Security Interest
Jul 6, 2026
From: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
To: NUVATION BIO INC.
Reel/Frame 075179/0564 →